Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: A randomized controlled trial with at least 5-year follow-up

Journal of the American Academy of Dermatology

Volumn 69, Issue 2, 2013, Pages 280-287

  Roozeboom, Marieke H ^a,b   Aardoom, Martine A ^a   Nelemans, Patty J ^a   Thissen, Monique R T M ^a,b   Kelleners Smeets, Nicole W J ^a,b   Kuijpers, Danielle I M ^c   Mosterd, Klara ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c AMPHIA HOSPITAL   (Netherlands)

Author keywords

aminolevulinic acid; failure; nodular basal cell carcinoma; photodynamic therapy; recurrence; surgical excision; thickness; treatment

Indexed keywords

AMINOLEVULINIC ACID; BF 200 ALA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER RECURRENCE; CANCER SURGERY; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INOPERABLE CANCER; MAJOR CLINICAL STUDY; MALE; NODULAR BASAL CELL CARCINOMA; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PUNCH BIOPSY; RANDOMIZED CONTROLLED TRIAL; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; THICKNESS; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR VOLUME;

ALA; AMINOLEVULINIC ACID; BASAL CELL CARCINOMA; BCC; CI; CONFIDENCE INTERVAL; FAILURE; MAL; METHYLAMINOLEVULINATE; NBCC; NODULAR BASAL CELL CARCINOMA; PDT; PHOTODYNAMIC THERAPY; RANDOMIZED CONTROLLED TRIAL; RCT; RECURRENCE; SURGICAL EXCISION; THICKNESS; TREATMENT;

ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; CARCINOMA, BASAL CELL; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; DERMATOLOGIC SURGICAL PROCEDURES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PHOTOCHEMOTHERAPY; RISK ASSESSMENT; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84880329711     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2013.02.014     Document Type: Article

References (42)

1. E. de Vries, L.V. van de Poll-Franse, W.J. Louwman, F.R. de Gruijl, and J.W. Coebergh Predictions of skin cancer incidence in The Netherlands up to 2015 Br J Dermatol 152 2005 481 488
2. S.C. Flohil, E. de Vries, H.A. Neumann, J.W. Coebergh, and T. Nijsten Incidence, prevalence and future trends of primary basal cell carcinoma in The Netherlands Acta Derm Venereol 91 2011 24 30
3. A. Lomas, J. Leonardi-Bee, and F. Bath-Hextall A systematic review of worldwide incidence of non-melanoma skin cancer Br J Dermatol 166 2012 1069 1080
4. N.R. Telfer, G.B. Colver, and C.A. Morton Guidelines for the management of basal cell carcinoma Br J Dermatol 159 2008 35 48
5. K. Mosterd, A.H. Arits, M.R. Thissen, and N.W. Kelleners-Smeets Histology-based treatment of basal cell carcinoma Acta Derm Venereol 89 2009 454 458
6. F.J. Bath-Hextall, W. Perkins, J. Bong, and H.C. Williams Interventions for basal cell carcinoma of the skin Cochrane Database Syst Rev 1 2007 CD003412
7. L.R. Braathen, R.M. Szeimies, N. Basset-Seguin, R. Bissonnette, P. Foley, and D. Pariser Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus: International Society for Photodynamic Therapy in Dermatology J Am Acad Dermatol 56 2007 125 143
8. A.M. Soler, T. Warloe, A. Berner, and K.E. Giercksky A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolevulinate-based photodynamic therapy alone and with prior curettage Br J Dermatol 145 2001 467 471
9. K. Mosterd, M.R. Thissen, P. Nelemans, N.W. Kelleners-Smeets, R.L. Janssen, and K.G. Broekhof Fractionated 5-aminolevulinic acid-photodynamic therapy vs surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial Br J Dermatol 159 2008 864 870
10. W.M. Star, A.J. van't Veen, D.J. Robinson, K. Munte, E.R. de Haas, and H.J. Sterenborg Topical 5-aminolevulinic acid mediated photodynamic therapy of superficial basal cell carcinoma using two light fractions with a two-hour interval: long-term follow-up Acta Derm Venereol 86 2006 412 417
11. C.S. Souza, L.B. Felicio, J. Ferreira, C. Kurachi, M.V. Bentley, and A.C. Tedesco Long-term follow-up of topical 5-aminolevulinic acid photodynamic therapy diode laser single session for non-melanoma skin cancer Photodiagn Photodyn Ther 6 2009 207 213
12. D.E. Rowe, R.J. Carroll, and C.L. Day Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up J Dermatol Surg Oncol 15 1989 315 328
13. A. Kaviani, L. Ataie-Fashtami, M. Fateh, N. Sheikhbahaee, M. Ghodsi, and N. Zand Photodynamic therapy of head and neck basal cell carcinoma according to different clinicopathologic features Lasers Surg Med 36 2005 377 382
14. B.D. Wilson, T.S. Mang, H. Stoll, C. Jones, M. Cooper, and T.J. Dougherty Photodynamic therapy for the treatment of basal cell carcinoma Arch Dermatol 128 1992 1597 1601
15. M.R. Thissen, C.A. Schroeter, and H.A. Neumann Photodynamic therapy with delta-aminolevulinic acid for nodular basal cell carcinomas using a prior debulking technique Br J Dermatol 142 2000 338 339
16. M.R. Thissen, M.W. de Blois, D.J. Robinson, H.S. de Bruijn, R.P. Dutrieux, and W.M. Star PpIX fluorescence kinetics and increased skin damage after intracutaneous injection of 5-aminolevulinic acid and repeated illumination J Invest Dermatol 118 2002 239 245
17. A.W. de Blois, M.R. Thissen, H.S. de Bruijn, R.J. Grouls, R.P. Dutrieux, and D.J. Robinson In vivo pharmacokinetics of protoporphyrin IX accumulation following intracutaneous injection of 5-aminolevulinic acid J Photochem Photobiol B 61 2001 21 29
18. N.W. Smeets, D.I. Kuijpers, P. Nelemans, J.U. Ostertag, M.E. Verhaegh, and G.A. Krekels Mohs' micrographic surgery for treatment of basal cell carcinoma of the face-results of a retrospective study and review of the literature Br J Dermatol 151 2004 141 147
19. C.A. Morton, R.M. MacKie, C. Whitehurst, J.V. Moore, and J.H. McColl Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response Arch Dermatol 134 1998 248 249
20. E. Christensen, P. Mjones, O.A. Foss, O.M. Rordam, and E. Skogvoll Pre-treatment evaluation of basal cell carcinoma for photodynamic therapy: comparative measurement of tumor thickness in punch biopsy and excision specimens Acta Derm Venereol 91 2011 651 654
21. I. Leibovitch, S.C. Huilgol, D. Selva, S. Richards, and R. Paver Basal cell carcinoma treated with Mohs surgery in Australia II: outcome at 5-year follow-up J Am Acad Dermatol 53 2005 452 457
22. K. Mosterd, G.A. Krekels, F.H. Nieman, J.U. Ostertag, B.A. Essers, and C.D. Dirksen Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomized controlled trial with 5-years' follow-up Lancet Oncol 9 2008 1149 1156
23. T. Rodriguez-Vigil, F. Vazquez-Lopez, and N. Perez-Oliva Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation J Am Acad Dermatol 56 2007 91 95
24. W.E. Love, J.D. Bernhard, and J.S. Bordeaux Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review Arch Dermatol 145 2009 1431 1438
25. D. Vidal, X. Matias-Guiu, and A. Alomar Fifty-five basal cell carcinomas treated with topical imiquimod: outcome at 5-year follow-up Arch Dermatol 143 2007 266 268
26. M.H. Roozeboom, A.H. Arits, P.J. Nelemans, and N.W. Kelleners-Smeets Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta-analysis of randomized and nonrandomized trials Br J Dermatol 167 2012 733 756
27. E. Christensen, E. Skogvoll, T. Viset, T. Warloe, and S. Sundstrom Photodynamic therapy with 5-aminolevulinic acid, dimethylsulfoxide and curettage in basal cell carcinoma: a 6-year clinical and histological follow-up J Eur Acad Dermatol Venereol 23 2009 58 66
28. T. Surrenti, L. De Angelis, A. Di Cesare, M.C. Fargnoli, and K. Peris Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: an open-label trial Eur J Dermatol 17 2007 412 415
29. R. Lindberg-Larsen, H. Solvsten, and K. Kragballe Evaluation of recurrence after photodynamic therapy with topical methylaminolevulinate for 157 basal cell carcinomas in 90 patients Acta Derm Venereol 92 2012 144 147
30. Cosgarea R, Susan M, Crisan M, Senila S. Photodynamic therapy using topical 5-aminolevulinic acid vs surgery for basal cell carcinoma. J Eur Acad Dermatol Venereol doi: 10.1111/j.1468-3083.2012.04619.x. Published online June 28, 2012.
31. C. Fritsch, B. Homey, W. Stahl, P. Lehmann, T. Ruzicka, and H. Sies Preferential relative porphyrin enrichment in solar keratoses upon topical application of delta-aminolevulinic acid methylester Photochem Photobiol 68 1998 218 221
32. Q. Peng, J. Moan, T. Warloe, V. Iani, H.B. Steen, and A. Bjorseth Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin J Photochem Photobiol B 34 1996 95 96
33. D.I. Kuijpers, M.R. Thissen, C.A. Thissen, and M.H. Neumann Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma J Drugs Dermatol 5 2006 642 645
34. E.R. de Haas, B. Kruijt, H.J. Sterenborg, H.A. Martino Neumann, and D.J. Robinson Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy J Invest Dermatol 126 2006 2679 2686
35. E.R. de Haas, H.C. de Vijlder, H.J. Sterenborg, H.A. Neumann, and D.J. Robinson Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer J Eur Acad Dermatol Venereol 22 2008 426 430
36. E. Christensen, C. Mork, and E. Skogvoll High and sustained efficacy after two sessions of topical 5-aminolevulinic acid photodynamic therapy for basal cell carcinoma: a prospective, clinical and histological 10-year follow-up study Br J Dermatol 166 2012 1342 1348
37. A.F. Hurlimann, G. Hanggi, and R.G. Panizzon Photodynamic therapy of superficial basal cell carcinomas using topical 5-aminolevulinic acid in a nanocolloid lotion Dermatology 197 1998 248 254
38. T. Maisch, F. Santarelli, S. Schreml, P. Babilas, and R.M. Szeimies Fluorescence induction of protoporphyrin IX by a new 5-aminolevulinic acid nanoemulsion used for photodynamic therapy in a full-thickness ex vivo skin model Exp Dermatol 19 2010 e302 e305
39. R.M. Szeimies, P. Radny, M. Sebastian, F. Borrosch, T. Dirschka, and G. Krahn-Senftleben Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study Br J Dermatol 163 2010 386 394
40. T. Dirschka, P. Radny, R. Dominicus, H. Mensing, H. Bruning, and L. Jenne Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicenter, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolevulinate cream and placebo Br J Dermatol 166 2012 137 146
41. A. Hauschild, E. Stockfleth, G. Popp, F. Borrosch, H. Bruning, and R. Dominicus Optimization of photodynamic therapy with a novel self-adhesive 5-aminolevulinic acid patch: results of two randomized controlled phase III studies Br J Dermatol 160 2009 1066 1074
42. R.M. Szeimies, E. Stockfleth, G. Popp, F. Borrosch, H. Bruning, and R. Dominicus Long-term follow-up of photodynamic therapy with a self-adhesive 5-aminolevulinic acid patch: 12 months data Br J Dermatol 162 2010 410 414